AU509348B2 - Quinazoline derivatives - Google Patents

Quinazoline derivatives

Info

Publication number
AU509348B2
AU509348B2 AU41576/78A AU4157678A AU509348B2 AU 509348 B2 AU509348 B2 AU 509348B2 AU 41576/78 A AU41576/78 A AU 41576/78A AU 4157678 A AU4157678 A AU 4157678A AU 509348 B2 AU509348 B2 AU 509348B2
Authority
AU
Australia
Prior art keywords
quinazoline derivatives
quinazoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU41576/78A
Other languages
English (en)
Other versions
AU4157678A (en
Inventor
S. F. Danielewicz J. C. and Greengrass C. W Campbell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp, Pfizer Inc filed Critical Pfizer Corp
Publication of AU4157678A publication Critical patent/AU4157678A/en
Application granted granted Critical
Publication of AU509348B2 publication Critical patent/AU509348B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU41576/78A 1977-11-16 1978-11-14 Quinazoline derivatives Expired AU509348B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB4758377 1977-11-16
GBGB47,583/7 1977-11-16
GB7844533A GB2010824B (en) 1977-11-16 1978-11-15 Therapeutic agents

Publications (2)

Publication Number Publication Date
AU4157678A AU4157678A (en) 1979-05-24
AU509348B2 true AU509348B2 (en) 1980-05-08

Family

ID=26266083

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41576/78A Expired AU509348B2 (en) 1977-11-16 1978-11-14 Quinazoline derivatives

Country Status (12)

Country Link
JP (1) JPS5481282A (nl)
AT (1) AT365183B (nl)
AU (1) AU509348B2 (nl)
BE (1) BE872023A (nl)
CA (1) CA1088068A (nl)
CH (1) CH637131A5 (nl)
DE (1) DE2849392A1 (nl)
FR (1) FR2409267A1 (nl)
GB (1) GB2010824B (nl)
LU (1) LU80531A1 (nl)
NL (1) NL174646C (nl)
SE (1) SE7811770L (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE800178L (en) * 1979-01-31 1980-07-31 Pfizer Ltd Derivatives of 4-amino-2-piperidinoquinazoline
FR2514353A2 (fr) * 1980-04-28 1983-04-15 Synthelabo Derives de piperidine et leur application en therapeutique
FR2481278A1 (fr) * 1980-04-28 1981-10-30 Synthelabo Nouveaux derives de piperidine, leur procede de preparation et leur application en therapeutique
JPS62212385A (ja) * 1986-03-13 1987-09-18 Kotobuki Seiyaku Kk キナゾリン誘導体並びに血圧降下剤及びその製法

Also Published As

Publication number Publication date
FR2409267B1 (nl) 1981-02-27
LU80531A1 (fr) 1980-06-05
NL174646B (nl) 1984-02-16
JPS5623991B2 (nl) 1981-06-03
CA1088068A (en) 1980-10-21
DE2849392A1 (de) 1979-05-23
JPS5481282A (en) 1979-06-28
FR2409267A1 (fr) 1979-06-15
AU4157678A (en) 1979-05-24
CH637131A5 (de) 1983-07-15
ATA816678A (de) 1981-05-15
NL7811236A (nl) 1979-05-18
SE7811770L (sv) 1979-05-17
GB2010824B (en) 1982-06-16
GB2010824A (en) 1979-07-04
BE872023A (fr) 1979-05-14
NL174646C (nl) 1984-07-16
AT365183B (de) 1981-12-28

Similar Documents

Publication Publication Date Title
AU518108B2 (en) Quinazoline compounds
AU522716B2 (en) Acylanilide derivatives
AU524339B2 (en) Tripherylalkene derivatives
AU518216B2 (en) Thienothiazine derivatives
AU506317B2 (en) Quinazoline derivatives
AU541144B2 (en) Aminoalkylbenzene derivatives
AU531493B2 (en) Thiohydantion derivatives
AU512266B2 (en) M-trifluoromethylphenylpiperazine derivatives
AU523183B2 (en) Ethoxygquin derivatives
AU515458B2 (en) Antioestrogenic phenylbut-1-ene derivatives
AU512057B2 (en) Meta-sulfonamido-benzamide derivatives
AU507066B1 (en) 2-Substituted-5-Hydroxy-1h-Imidazole 4-Carbozamide Derivatives
AU506410B2 (en) Quinazoline derivatives
AU515104B2 (en) Oxadiazolopyrimidine derivatives
AU520334B2 (en) 25-alkylcholesterol derivatives
AU521883B2 (en) Pyranochromone derivatives
AU519005B2 (en) Phenylacycloakane derivatives
AU517387B2 (en) Tetracyclononane derivatives
AU502293B1 (en) 4-amino-oleandomycin derivatives
AU516948B2 (en) Fortimicing derivatives
AU509348B2 (en) Quinazoline derivatives
AU507828B2 (en) Quinazoline derivatives
AU516891B2 (en) Pregn-4-ene derivatives
AU516829B2 (en) Pyrimidine derivatives
AU512364B2 (en) Phenylformamidine derivatives